Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard H Bailey
University of Wisconsin Chemoprevention Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- South Orange County Surgical Medical Group Inc
Laguna Hills, California, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Accumed Research Associates
Garden City, New York, United States
- University of Rochester
Rochester, New York, United States
- Urology San Antonio Research Pa
San Antonio, Texas, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
- University of Wisconsin Chemoprevention Consortium
Madison, Wisconsin, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
- Prohealth Waukesha Memorial Hospital
Waukesha, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jun 2005
- Primary completion
- 15 Aug 2010
- Completion
- 15 Aug 2010
- Last update posted
- 10 Jun 2021
- Registered enrollment
- 60
- Registry id
- NCT00118040
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.